If the Trump administration goes through with a plan to make major cuts to the Centers for Disease Control and Prevention’s HIV division, Georgia and other states in the Southeast would struggle to ...

Gov. Glenn Youngkin (R) took action against several bills on Monday, including legislation that would have raised minimum ...

HIV doesn’t cause urinary symptoms on its own but may increase your risk of a health condition, such as a urinary tract infection or kidney damage, that can lead to symptoms. Living with HIV can ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term protection. If this yearly injection is approved and widely implemented ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

WASHINGTON, March 18 (Reuters) - The U.S. health department said on Tuesday it is reviewing the Centers for Disease Control and Prevention's HIV prevention division for overlap with other ...

Trump once pledged to end HIV/AIDS in the U.S. by 2030. Now his administration is reportedly looking to slash funding for domestic HIV prevention programs ...

Mark Lal had already seen three friends die of HIV before he received his diagnosis. When he tested positive for the virus, he knew what could come next. "They started to lose a lot of weight ...

When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.

Many treatments can help people with HIV live longer, more fulfilling lives. The main treatment for HIV is antiretroviral medication. Every year, researchers are investigating new therapies in the ...

With no other programs to replace them, cuts to the Centers for Disease Control and Prevention’s HIV Prevention Division could jeopardize progress in addressing the nation’s HIV epidemic and ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet medical journal. Lenacapavir stops ...